- Merck KGaA (FRA:MRK) publishes 2009-10 Corporate Responsibility Report

The report demonstrates how the company assumes responsibility for and with its pharmaceutical, chemical and life science products.
May 17, 2011 10:17 AM ET

 (3BL Media / theCSRfeed) May 17, 2011 - Merck KGaA of Darmstadt, Germany, has published its fifth Corporate Responsibility Report, for the years 2009 and 2010. It is available at:

Firmly anchored in values, Corporate Responsibility is a basic principle of Merck’s management and its strategy. The report demonstrates how Merck assumes responsibility for and with its pharmaceutical, chemical and life science products. This not only includes the safety of products but also explains how its products can lead to a better world, e.g. chemicals that can improve harnessing and storage of renewable energy.

Other initiatives and goals described in the report are the reduction of greenhouse gas emissions, employee diversity with the new target to increase the share of women in management to between 25% and 30% by 2016, and the Merck Praziquantel Donation Program to fight the tropical disease Schistosomiasis together with the World Health Organization.

A comprehensive “Facts and Figures” section provides detailed information on the company’s performance and progress.

The reporting is based on the G3 guidelines of the Global Reporting Initiative (GRI). Merck self-declares an Application Level of B+. For selected performance indicators, Merck has received a Limited Assurance audit certificate from an external auditor. The report also documents the progress in implementing the principles of the United Nations’ Global Compact.

To make comments or to order a hard copy, please contact

Merck is a global pharmaceutical and chemical company with total revenues of € 9.3 billion in 2010, a history that began in 1668, and a future shaped by more than 40,000 employees in 67 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.